-
s Aeroallergen-specific Immunotherapy and Biologics Co-administration: Cost-benefit Re-considerations are Urgently Needed
- Source: Recent Advances in Inflammation & Allergy Drug Discovery, Volume 17, Issue 2, Sep 2023, p. 85 - 87
-
- 01 Sep 2023
Preview this article:




Aeroallergen-specific Immunotherapy and Biologics Co-administration: Cost-benefit Re-considerations are Urgently Needed, Page 1 of 1
< Previous page Next page > /docserver/preview/fulltext/raiad/17/2/s2-1.gif
There is no abstract available.
© Bentham Science Publishers